🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

6+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 6 recruiting trials for “Myelodysplastic neoplasm with low blasts”

NARecruitingNCT07328191 ↗

Quality of Life-Guided Transfusion in Refractory MDS or AML

👨‍⚕️ Thomas Cluzeau, Centre Hospitalier Universitaire de Nice📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07019155 ↗

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

👨‍⚕️ Sung-Yun Pai, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT06918834 ↗

Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 5 sites📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT05924100 ↗

Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

🏥 Associazione Qol-one📍 23 sites📅 Started Nov 2022View details ↗
Phase 1RecruitingNCT05473910 ↗

A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

👨‍⚕️ Michelle Matzko, MD, Tscan Therapeutics📍 15 sites📅 Started Nov 2022View details ↗
RecruitingNCT02269592 ↗

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

👨‍⚕️ Irene Ghobrial, MD, Dana-Farber Cancer Institute📍 7 sites📅 Started Aug 2014View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →